aromatase inhibitor - Robuta Search

https://www.cochrane.org/de/evidence/CD013167_systemic-therapies-preventing-or-treating-aromatase-inhibitor-induced-musculoskeletal-symptoms-early Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms... systemic therapies aromatase inhibitor preventing https://www.medicaldaily.com/study-sheds-light-aromatase-inhibitor-joint-pain-syndrome-234300 Study sheds light on aromatase inhibitor joint pain syndrome Nov 8, 2010 - Breast cancer patients are more likely to have joint pain from taking aromatase inhibitors (AIs) if they have advanced stage cancer, according to a study... sheds light aromatase inhibitor joint pain study syndrome https://www.breastcancer.org/podcast/aromatase-inhibitor-pain How to Ease Aromatase Inhibitor-Related Pain Ashish Khanna, MD, talks about aromatase inhibitors, why they cause joint pain, and how to ease this pain using exercise and other methods. how to aromatase inhibitor ease related pain https://pmc.ncbi.nlm.nih.gov/articles/PMC5794008/ Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic... Testosterone (T) replacement is being increasingly offered to older men with age-related decline in testosterone levels. The effects of long-term testosterone... aromatase inhibitor older men https://www.news-medical.net/news/20250813/New-compound-shows-promise-against-aromatase-inhibitor-resistant-breast-cancer.aspx New compound shows promise against aromatase inhibitor-resistant breast cancer Aug 13, 2025 - A new research paper was published in Volume 16 of Oncotarget on July 29, 2025, titled "PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in... aromatase inhibitor new compound shows promise https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-lapatinib-herceptin-and-aromatase-inhibitor-for-advanced-breast-cancer A trial looking at lapatinib, Herceptin and an aromatase inhibitor for advanced breast cancer This trial is looking at lapatinib, Herceptin (also known as trastuzumab) and hormone therapy as the first treatment for breast cancer that has spread https://www.estrohalt.com/ Estrohalt | Estrogen Blocker and Natural Aromatase Inhibitor Estrohalt is an estrogen blocker for men and women which contains natural aromatase inhibitors in DIM and Indole-3-Carbinol estrogen blocker natural aromatase inhibitor https://www.sciencedaily.com/releases/2015/05/150507123027.htm Nuclear medicine scan could identify who might benefit from aromatase inhibitor treatment |... A new, noninvasive nuclear medicine test can be used to determine whether aromatase inhibitor treatment will be effective for specific cancer patients,... nuclear medicine https://www.breastcancer.org/research-news/20110919 Prolia Approved by FDA to Treat Bone Loss in Women Taking Aromatase Inhibitor The osteoporosis drug denosumab (Prolia) is now FDA-approved to treat bone loss in women taking aromatase inhibitors. https://www.breastcancer.org/research-news/obesity-higher-recurrence-aromatase-inhibitors Study: Obesity Ups Recurrence Risk After Aromatase Inhibitor Obesity increases recurrence risk in post-menopausal women with hormone receptor-positive breast cancer who took an aromatase inhibitor. study obesity ups recurrence risk https://www.racgp.org.au/clinical-resources/clinical-guidelines/guidelines-by-topic/view-all-guidelines-by-topic/chronic-disease/osteoporosis/special-issues/bone-loss RACGP - Bone loss associated with aromatase inhibitor therapy for breast cancer and androgen... Baseline assessment includes review of clinical risk factors, blood and urine laboratory testing (electrolytes, calcium, alkaline phosphatase and 25-OH vitamin... https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-kisqali-aromatase-inhibitor-and-kisqali-femara-co-pack-early-high-risk-breast-cancer FDA approves Kisqali with an aromatase inhibitor and Kisqali Femara Co-Pack for early high-risk... On September 17, 2024, the FDA approved ribociclib (Kisqali, Novartis Pharmaceuticals Corporation) with an aromatase inhibitor and ribociclib and letrozole... https://www.breastcancer.org/research-news/20140207-3 Women Who Have Aromatase Inhibitor Side Effects Before Starting Medicine Less Likely to Finish... Research suggests that women who are having side effects commonly associated with aromatase inhibitors BEFORE they start taking an aromatase inhibitor are much... https://www.breastcancer.org/podcast/aromatase-inhibitor-length Does 2.5 to 5 More Years of an Aromatase Inhibitor Offer Benefits? Maybe, For Some Women: 2016 San... Terry Mamounas, MD, MPH discusses who may benefit from extra years of an aromatase inhibitor. https://www.breastcancer.org/research-news/cdk46-inhibitor-plus-ai-helps-despite-age CDK4/6 Inhibitor and Aromatase Inhibitor Effective At Any Age CDK4/6 inhibitors combined with an aromatase inhibitor to treat metastatic, hormone receptor-positive, HER2-negative breast cancer is effective for women at... cdk4 6 inhibitor aromatase effective age